Fenofibrate inhibits adipocyte hypertrophy and insulin resistance by activating adipose PPARα in high fat diet-induced obese mice

Experimental and Molecular Medicine

Volumn 41, Issue 6, 2009, Pages 397-405

  Jeong, Sunhyo ^a   Yoon, Michung ^a  

^a Mokwon University   (South Korea)

Author keywords

Adipocytes; Hyperglycemia; Hyperlipidemia; Insulin resistance; PPAR

Indexed keywords

FATTY ACID; FENOFIBRATE; GLUCOSE; INSULIN; LEPTIN; LIPID; MESSENGER RNA; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR ALPHA; TRIACYLGLYCEROL; TUMOR NECROSIS FACTOR ALPHA;

ADIPOCYTE; ADIPOSE TISSUE; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CELL DIFFERENTIATION; CELL SIZE; CELL STRAIN 3T3; CONTROLLED STUDY; EPIDIDYMIS FAT; FATTY ACID OXIDATION; GENE TARGETING; GLUCOSE TOLERANCE TEST; HISTOPATHOLOGY; HYPERGLYCEMIA; HYPERLIPIDEMIA; HYPERTROPHY; IMPAIRED GLUCOSE TOLERANCE; INHIBITION KINETICS; INSULIN RESISTANCE; INSULIN SENSITIVITY; INTRAABDOMINAL FAT; LIPID DIET; LIPOLYSIS; MARKER GENE; MOUSE; NONHUMAN; OBESITY; PROTEIN EXPRESSION; TREATMENT DURATION;

MUS; RODENTIA;

EID: 67649659650     PISSN: 12263613     EISSN: 20926413     Source Type: Journal    
DOI: 10.3858/emm.2009.41.6.045     Document Type: Article

References (46)

1. Ahima RS. Adipose tissue as an endocrine organ. Obesity 2006;14 Suppl 5:242S-9S
2. Akiyama TE, Nicol CJ, Fievet C, Staels B, Ward JM, Auwerx J, Lee SS, Gonzalez FJ, Peters JM. Peroxisome proliferator-activated receptor-alpha regulates lipid homeostasis, but is not associated with obesity: studies with congenic mouse lines. J Biol Chem 2001;276:39088-39093 (Pubitemid 37371277)
3. Boden G, Chen X, Ruiz J, White JV, Rossetti L. Mechanisms of fatty acid-induced inhibition of glucose uptake. J Clin Invest 1994;93:2438-2446 (Pubitemid 24177157)
4. Boden G. Role of fatty acids in the pathogenesis of insulin resistance and NIDDM. Diabetes 1997;46:3-10 (Pubitemid 27009941)
5. Boden G. Free fatty acids and insulin secretion in humans. Curr Diab Rep 2005;5:167-170 (Pubitemid 41599940)
6. Bogacka I, Xie H, Bray GA, Smith SR. Pioglitazone induces mitochondrial biogenesis in human subcutaneous adipose tissue in vivo. Diabetes 2005;54:1392-1399 (Pubitemid 40586669)
7. Bossé Y, Després JP, Bouchard C, Pérusse L, Vohl MC. The peroxisome proliferator-activated receptor alpha L162V mutation is associated with reduced adiposity. Obes Res 2003;11:809-816 (Pubitemid 41137517)
8. Brun RP, Kim JB, Hu E, Spiegelman BM. Peroxisome proliferator-activated receptor gamma and the control of adipogenesis. Curr Opin Lipidol 1997;8:212-218 (Pubitemid 27354588)
9. Brunzell JD, Hokanson JE. Dyslipidemia of central obesity and insulin resistance. Diabetes Care 1999;22:C10-C3 (Pubitemid 29164911)
10. Bulcao C, Ferreira SR, Giuffrida FM, Ribeiro-Filho FF. The new adipose tissue and adipocytokines. Curr Diab Rep 2006;2:19-28 (Pubitemid 44096614)
11. Cabrero A, Alegret M, Sánchez RM, Adzet T, Laguna JC, Vázquez M. Bezafibrate reduces mRNA levels of adipocyte markers and increases fatty acid oxidation in primary culture of adipocytes. Diabetes 2001;50:1883-1890 (Pubitemid 33641610)
12. Ceddia RB, William WN Jr, Lima FB, Curi R. Leptin inhibits insulin-stimulated incorporation of glucose into lipids and stimulates glucose decarboxylation in isolated rat adipocytes. J Endocrinol 1998;158:R7-R9 (Pubitemid 28407554)
13. de Souza CJ, Eckhardt M, Gagen K, Dong M, Chen W, Laurent D, Burkey BF. Effects of pioglitazone on adipose tissue remodeling within the setting of obesity and insulin resistance. Diabetes 2001;50:1863-1871 (Pubitemid 33641608)
14. Flier JS. Obesity wars: molecular progress confronts an expanding epidemic. Cell 2004;116:337-350 (Pubitemid 38167322)
15. Holness MJ, Smith ND, Greenwood GK, Sugden MC. Acute (24 h) activation of peroxisome proliferator-activated receptor-alpha (PPARalpha) reverses high-fat feeding-induced insulin hypersecretion in vivo and in perifused pancreatic islets. J Endocrinol 2003;177:197-205 (Pubitemid 36656392)
16. Hotamisligil GS, Shargill NS, Spiegelman BM. Adipose expression of tumor necrosis factor-alpha: direct role in obesity-linked insulin resistance. Science 1993;259:87-91 (Pubitemid 23036092)
17. Hotamisligil GS, Peraldi P, Budavari A, Ellis R, White MF, Spiegelman BM. IRS-1-mediated inhibition of insulin receptor tyrosine kinase activity in TNF-alpha- and obesity-induced insulin resistance. Science 1996;271:665-668 (Pubitemid 26052915)
18. Ide T, Shimano H, Yoshikawa T, Yahagi N, Amemiya-Kudo M, Matsuzaka T, Nakakuki M, Yatoh S, Iizuka Y, Tomita S, Ohashi K, Takahashi A, Sone H, Gotoda T, Osuga J, Ishibashi S, Yamada N. Cross-talk between peroxisome proliferator-activated receptor (PPAR) alpha and liver X receptor (LXR) in nutritional regulation of fatty acid metabolism. II. LXRs suppress lipid degradation gene promoters through inhibition of PPAR signaling. Mol Endocrinol 2003;17:1255-1267
19. Jensen MD. Is visceral fat involved in the pathogenesis of the metabolic syndrome? Human model. Obesity (Silver Spring) 2006;14:20S-4S
20. Jeong S, Han M, Lee H, Kim M, Nicol CJ, Kim BH, Choi JH, Oh GT, Yoon M. Effects of fenofibrate on high fat diet-induced body weight gain and adiposity in female? C57BL/6J mice. Metabolism 2004a;53:1284-1289 (Pubitemid 39222088)
21. Jeong S, Kim M, Han M, Lee H, Ahn J, Kim M, Song YH, Shin C, Nam KH, Kim TW, Oh GT, Yoon M. Fenofibrate prevents obesity and hypertriglyceridemia in LDL receptor-null mice. Metabolism 2004b;53:607-613 (Pubitemid 38596533)
22. Jeong S, Yoon M. Troglitazone lowers serum triglycerides with sexual dimorphism in C57BL/6J mice. J Exp Biomed Sci 2006;12:65-72
23. Jeong S, Yoon M. Inhibition of the actions of peroxisome proliferator-activated receptor α on obesity by estrogen. Obesity 2007;15:1430-1440
24. Kadowaki T. Insights into insulin resistance and type 2 diabetes from knockout mouse models. J Clin Invest 2000;106:459-465 (Pubitemid 30666378)
25. Kissebah AH. Central obesity: measurement and metabolic effects. Diabetes Rev 1997;5:8-20 (Pubitemid 27198911)
26. Kliewer SA, Lehmann JM, Wilson TM. Orphan nuclear receptors: shifting endocrinology into reverse. Science 1999;284:757-760 (Pubitemid 29291332)
27. Koh EH, Kim MS, Park JY, Kim HS, Youn JY, Park HS, Youn JH, Lee KU. Peroxisome proliferator-activated receptor (PPAR)-alpha activation prevents diabetes in OLETF rats: comparison with PPAR-gamma activation. Diabetes 2003;52:2331-2337 (Pubitemid 37059504)
28. Kralisch S, Sommer G, Deckert CM, Linke A, Bluher M, Stumvoll M, Fasshauer M. Adipokines in diabetes and cardiovascular diseases. Minerva Endocrinol 2007;32:161-171
29. Kubota N, Terauchi Y, Miki H, Tamemoto H, Yamauchi T, Komeda K, Satoh S, Nakano R, Ishii C, Sugiyama T, Eto K, Tsubamoto Y, Okuno A, Murakami K, Sekihara H, Hasegawa G, Naito M, Toyoshima Y, Tanaka S, Shiota K, Kitamura T, Fujita T, Ezaki O, Aizawa S, Kadowaki T, et al. PPAR gamma mediates high-fat diet-induced adipocyte hypertrophy and insulin resistance. Mol Cell 1999;4:597-609 (Pubitemid 29531139)
30. Lalloyer F, Vandewalle B, Percevault F, Torpier G, Kerr-Conte J, Oosterveer M, Paumelle R, Fruchart JC, Kuipers F, Pattou F, Fiévet C, Staels B. Peroxisome proliferator-activated receptor alpha improves pancreatic adaptation to insulin resistance in obese mice and reduces lipotoxicity in human islets. Diabetes 2006;55:1605-1613 (Pubitemid 44324112)
31. Lefebvre P, Chinetti G, Fruchart JC, Staels B. Sorting out the roles of PPAR alpha in energy metabolism and vascular homeostasis. J Clin Invest 2006;116:571-580 (Pubitemid 43326861)
32. Maffei M, Fei H, Lee GH, Dani C, Leroy P, Zhang Y, Proenca R, Negrel R, Ailhaud G, Friedman JM. Increased expression in adipocytes of ob RNA in mice with lesions of the hypothalamus and with mutations at the db locus. Proc Natl Acad Sci USA 1995;92:6957-6960
33. Matsuzawa Y. The metabolic syndrome and adipocytokines. FEBS Lett 2006;580:2917-2921 (Pubitemid 43729162)
34. Murphy JE, Zhou S, Giese K, Williams LT, Escobedo JA, Dwarki VJ. Long-term correction of obesity and diabetes in genetically obese mice by a single intramuscular injection of recombinant adeno-associated virus encoding mouse leptin. Proc Natl Acad Sci USA 1997;94:13921-13926 (Pubitemid 28009685)
35. Okamoto Y, Higashiyama H, Inoue H, Kanematsu M, Kinoshita M, Asano S. Quantitative image analysis in adipose tissue using an automated image analysis system: differential effects of peroxisome proliferator-activated receptor-alpha and -gamma agonist on white and brown adipose tissue morphology in AKR obese and db/db diabetic mice. Pathol Int 2007;57:369-377 (Pubitemid 46849037)
36. Okuno A, Tamemoto H, Tobe K, Ueki K, Mori Y, Iwamoto K, Umesono K, Akanuma Y, Fujiwara T, Horikoshi H, Yazaki Y, Kadowaki T. Troglitazone increases the number of small adipocytes without the change of white adipose tissue mass in obese Zucker rats. J Clin Invest 1998;101:1354-1361 (Pubitemid 28145252)
37. Roden M, Price TB, Perseghin G, Petersen KF, Rothman DL, Cline GW, Shulman GI. Mechanism of free fatty acid-induced insulin resistance in humans. J Clin Invest 1996;97: 2859-2865 (Pubitemid 26197099)
38. Schoonjans K, Staels B, Auwerx J. Role of the peroxisome proliferator-activated receptor (PPAR) in mediating the effects of fibrates and fatty acids on gene expression. J Lipid Res 1996;37:907-925 (Pubitemid 26182326)
39. Spiegelman BM, Flier JS. Adipogenesis and obesity: rounding out the big picture. Cell 1996;87:377-389 (Pubitemid 26374313)
40. Staels B, Dallongeville J, Auwerx J, Schoonjans K, Leitersdorf E, Fruchart JC. Mechanism of action of fibrates on lipid and lipoprotein metabolism. Circulation 1998;98:2088-2093 (Pubitemid 28512236)
41. Taylor SI, Barr V, M. Reitman M. Does leptin contribute to diabetes caused by obesity? Science 1996;274:1151-1152
42. Vazquez M, Roglans N, Cabrero A, Rodríguez C, Adzet T, Alegret M, Sanchez RM, Laguna JC. Bezafibrate induces acyl-CoA oxidase mRNA levels and fatty acid peroxisomal beta-oxidation in rat white adipose tissue. Mol Cell Biochem 2001;216:71-78 (Pubitemid 32142226)
43. Wellen KE, Hotamisligil GS. Inflammation, stress, and diabetes. J Clin Invest 2005;115:1111-1119 (Pubitemid 40629025)
44. Wickelgren I. Obesity: how big a problem? Science 1998;280:1364-1367
45. Yoon M, Jeong S, Nicol CJ, Lee H, Han M, Kim JJ, Seo YJ, Ryu C, Oh GT. Fenofibrate regulates obesity and lipid metabolism with sexual dimorphism. Exp Mol Med 2002;34:481-488 (Pubitemid 36114367)
46. Yoon M, Jeong S, Lee H, Han M, Kang JH, Kim EY, Kim M, Oh GT. Fenofibrate improves lipid metabolism and obesity in ovariectomized LDL receptor-null mice. Biochem Biophys Res Commun 2003;302:29-34 (Pubitemid 36268914)